Close

Analyst Ratings for Orchard Therapeutics (ORTX) [Sells]

ORTX Rating Summary

ORTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ORTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $25.00 (+49.7%) * Over Last 12-Mos
Rating Score: 6 / 10   Percentile Rank: 65%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/16/2021 JPMorgan Anupam Rama Downgrade Underweight
(Neutral)
N/A
(N/A)
1.77
(16.70)
843.5% Details